These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 28343355
21. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus. Gargiulo Mde L, Gómez G, Khoury M, Collado MV, Suárez L, Álvarez C, Sarano J. Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896 [Abstract] [Full Text] [Related]
22. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis. Yang XW, Tan Y, Yu F, Zhao MH. Nephrol Dial Transplant; 2012 Sep; 27(9):3552-9. PubMed ID: 22700716 [Abstract] [Full Text] [Related]
23. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Kozyro I, Perahud I, Sadallah S, Sukalo A, Titov L, Schifferli J, Trendelenburg M. Pediatrics; 2006 May; 117(5):1663-8. PubMed ID: 16651321 [Abstract] [Full Text] [Related]
24. Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis. de Liso F, Matinato C, Novembrino C, Radice A, Raffiotta F, Ronchi M, Croci MD, Sinico RA, Messa P, Torresani E, Moroni G. Clin Chem Lab Med; 2015 Oct; 53(11):1771-7. PubMed ID: 25870967 [Abstract] [Full Text] [Related]
25. Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus. Sjöwall C, Bentow C, Aure MA, Mahler M. J Immunol Res; 2018 Oct; 2018():1294680. PubMed ID: 30246032 [Abstract] [Full Text] [Related]
26. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S, Migliorini P. J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471 [Abstract] [Full Text] [Related]
27. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis. Sjöwall C, Olin AI, Skogh T, Wetterö J, Mörgelin M, Nived O, Sturfelt G, Bengtsson AA. Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132 [Abstract] [Full Text] [Related]
28. Anti-C1q antibody in patients with lupus nephritic flare: 18-month follow-up and a nested case-control study. Fatemi A, Samadi G, Sayedbonakdar Z, Smiley A. Mod Rheumatol; 2016 May; 26(2):233-9. PubMed ID: 26357965 [Abstract] [Full Text] [Related]
29. Anti-C1q autoantibodies in lupus nephritis. Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G. Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131 [Abstract] [Full Text] [Related]
30. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Seelen MA, Trouw LA, Daha MR. Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199 [Abstract] [Full Text] [Related]
31. Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis. Miguel DF, Terreri MT, Pereira RMR, Bonfá E, Silva CAA, Corrente JE, Magalhaes CS, Brazilian Childhood-onset Systemic Lupus Erythematosus Group. Adv Rheumatol; 2020 Feb 01; 60(1):10. PubMed ID: 32005292 [Abstract] [Full Text] [Related]
32. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis. Chen PC, Wang CR, Liu MF, Chen FF, Liang CC. Asian Pac J Allergy Immunol; 2002 Dec 01; 20(4):223-7. PubMed ID: 12744622 [Abstract] [Full Text] [Related]
33. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis. Colliard S, Jourde-Chiche N, Clavarino G, Sarrot-Reynauld F, Gout E, Deroux A, Fougere M, Bardin N, Bouillet L, Cesbron JY, Thielens NM, Dumestre-Pérard C. Arthritis Care Res (Hoboken); 2018 Aug 01; 70(8):1263-1268. PubMed ID: 29045037 [Abstract] [Full Text] [Related]
34. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis. Elshweikh SA, Elkhouly RM, Shaalan MM, Shorbagy SH. Egypt J Immunol; 2014 Aug 01; 21(2):49-59. PubMed ID: 25812352 [Abstract] [Full Text] [Related]
35. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis]. Zhang FC, Zhou B, Dong Y. Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001 [Abstract] [Full Text] [Related]
36. Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity. Bernstein KA, Kahl LE, Balow JE, Lefkowith JB. Clin Exp Immunol; 1994 Oct 13; 98(1):60-5. PubMed ID: 7923886 [Abstract] [Full Text] [Related]
37. Anti-C1q in systemic lupus erythematosus. Stojan G, Petri M. Lupus; 2016 Jul 13; 25(8):873-7. PubMed ID: 27252264 [Abstract] [Full Text] [Related]
38. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations. Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL. Semin Arthritis Rheum; 2012 Jun 13; 41(6):840-8. PubMed ID: 22177108 [Abstract] [Full Text] [Related]
39. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis. Bigler C, Hopfer H, Danner D, Schaller M, Mihatsch MJ, Trendelenburg M. Nephrol Dial Transplant; 2011 Apr 13; 26(4):1220-8. PubMed ID: 20841491 [Abstract] [Full Text] [Related]
40. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis. Soliman AF, Egailla SE, Abdel-Gawad ER, Mansour AI, ElKhouly TH, Mahgoub MY. Egypt J Immunol; 2016 Jan 13; 23(1):107-116. PubMed ID: 28502158 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]